Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi's New Diabetes & CV Head Guenter Has Difficult Job Ahead

Executive Summary

Sanofi SA's CEO Olivier Brandicourt has shaken up his top management team for the second time since taking over the reins last year, changing the head of its key diabetes franchise in an urgent effort to turn things round. He clearly hopes Peter Guenter's wide-ranging commercial insights can help achieve that.

You may also be interested in...



Sanofi Seeks Medivation Board Overhaul As Buyout Bid Remains Rejected

Sanofi is putting more pressure on Medivation to accept its $9.3bn acquisition offer by proposing to replace the biotechnology company's and Xtandi developer's entire board of directors.

Sanofi Earnings Emphasize Need For Medivation Buy

Sanofi clearly would benefit from its proposed $9.3bn purchase of Medivation Inc. based on the French company's first quarter earnings, which show a pharmaceuticals business that's suffering from competition, US drug pricing pressures and foreign currency exchange issues.

Brandicourt's 'Big Reveal' Falls Flat For Sanofi

Seven months into the job and the shine is wearing off Sanofi's new CEO Olivier Brandicourt. His first 'Meet the Management' investor day on Nov. 6 left analysts underwhelmed and shares slipping.

Topics

Latest News
See All
UsernamePublicRestriction

Register

SC065263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel